Discover the latest science based breakthroughs
in health, medicine and new drug approvals
Why Are More People Struggling to Control High Blood Pressure?
What Did the Research Discover? High blood pressure (hypertension)...
Videos
Latest Posts
FDA Approves Omvoh for Ulcerative Colitis Treatment: A New Solution as of October 26, 2023
What is Omvoh prescribed for? Omvoh is prescribed...
FDA Greenlights Agamree for Duchenne Muscular Dystrophy on October 26, 2023
What is Agamree prescribed for? Agamree is prescribed...
FDA Approves Bimzelx for Plaque Psoriasis: A New Hope for Patients as of October 17, 2023
What is Bimzelx prescribed for? Bimzelx is prescribed to treat...
FDA Approves Zilbrysq for Myasthenia Gravis on October 17, 2023
What is Zilbrysq prescribed for? Zilbrysq is prescribed...
FDA Approves Velsipity for Ulcerative Colitis Treatment on October 13, 2023
What is Velsipity prescribed for? Velsipity is prescribed to...
FDA Approves Rivfloza for Late-Onset Pompe Disease on September 28, 2023
What is Rivfloza prescribed for? Rivfloza is used to...
FDA Approves DAYBUE for Treating Rett Syndrome Symptoms on March 10, 2023
What is DAYBUE prescribed for? DAYBUE (generic name:...
FDA Approves ZAVZPRET Nasal Spray for Rapid Relief of Acute Migraine Symptoms on March 2023
What is ZAVZPRET prescribed for? ZAVZPRET is...
FDA Approves SKYCLARYS to Aid Friedreich’s Ataxia Patients on February 28, 2023
What is SKYCLARYS prescribed for? SKYCLARYS is...
FDA Approves FILSPARI to Aid Kidney Health in IgA Nephropathy on February 2023
What is FILSPARI prescribed for? FILSPARI is...
FDA Approval on February 16, 2023: LAMZEDE Breakthrough for Alpha-Mannosidosis Treatment
What is LAMZEDE prescribed for? For the...
Introducing POMBILITI: A New FDA-Approved Treatment for Late-Onset Pompe Disease as of September 28, 2023
What is POMBILITI prescribed for? POMBILITI is...
EXXUA: A Groundbreaking Step for Treating Major Depression Approved on September 22, 2023
What is EXXUA prescribed for? EXXUA is prescribed...
OJJAARA: A New Treatment for Myelofibrosis Approved by the FDA on September 15, 2023
What is OJJAARA prescribed for? OJJAARA is prescribed to treat...
APHEXDA: A New Frontier in Multiple Myeloma Treatment Approved by the FDA on September 8, 2023
What is APHEXDA prescribed for? APHEXDA is used in combination...
FDA Approves VEOPOZ on August 18th 2023: A New Treatment for CHAPLE Disease
What is VEOPOZ prescribed for? VEOPOZ is prescribed to...
FDA Approves JESDUVROQ for Anemia in Chronic Kidney Disease Patients on Dialysis on February 1, 2023
What is JESDUVROQ prescribed for? To treat anemia caused...
FDA Approves ORSERDU for Advanced Breast Cancer on January 27, 2023
What is ORSERDU prescribed for? For treatment of...
ScienceMyHealth delivers the latest updates on new drug approvals and groundbreaking medical research from the Food and Drug Administration, leading scientific journals, and top universities.
With new stories and videos posted daily, subscribers can stay informed and receive alerts to explore and find clinical trials relevant to their interests.
Trending News
Revolutionary Eye Drops May Offer Future Non-Surgical Treatment for Cataracts
What Did the Research Discover? Cataracts are a leading cause of vision loss worldwide, affecting millions of people. As people age, the risk of developing cataracts increases, and while surgery is effective, it is expensive and not always available in all areas....
Research Progress for Chronic Bronchitis: Sulforaphane Strengthens Lung Defenses
What did the research discover? Researchers studied how activating a specific protein called Nrf2 could help the immune cells in the lungs, called alveolar macrophages, fight bacterial infections in chronic obstructive pulmonary disease (COPD). COPD makes it harder...
Understanding Sunscreen Safety and Effectiveness
What did the research discover? This study investigated how zinc oxide (ZnO) affects the safety and effectiveness of sunscreen ingredients when exposed to UV light. Sunscreens are generally tested based on individual ingredients, but their stability and safety depend...
The Future of Alzheimer’s Drugs: A New Direction
What did the research discover? A review of the 2024 Alzheimer's disease (AD) drug pipeline found 164 clinical trials testing 127 drugs, a decline from 187 trials and 141 drugs in 2023. The pipeline consists of: 48 trials in Phase 3 (testing 32 drugs) 90 trials in...
Daily Aspirin Use Can Increase Likelihood of Anemia in Older Adults
What did the research discover? Researchers wanted to find out if taking a small dose of aspirin every day could lead to anemia (a condition where you don’t have enough healthy red blood cells) and lower iron levels in the blood. To do this, they analyzed data from a...
Your Sleep Pattern Could Affect Your Risk of Diabetes
What did the research discover? This study looked at how a person’s chronotype—whether they are a "morning person" or "night owl"—affects their risk of developing type 2 diabetes and whether lifestyle choices play a role. Researchers followed 63,676 middle-aged nurses...
FDA Greenlights Agamree for Duchenne Muscular Dystrophy on October 26, 2023
What is Agamree prescribed for? Agamree is prescribed for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older. What is Agamree and what does it do? Agamree, pronounced ah gam' ree, (generic name: vamorolone), is a...
FDA Approves Bimzelx for Plaque Psoriasis: A New Hope for Patients as of October 17, 2023
What is Bimzelx prescribed for? Bimzelx is prescribed to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. What is Bimzelx and what does it do? Bimzelx, pronounced bim zel’ ex, (generic name:...